I went to bed feeling fine but woke up paralysed – doctors blamed it on constipation but the truth was horrifying
But when he went to bed feeling perfectly well one night and woke up unable to stand, it was the start of a nightmare which would lead to a shattering diagnosis for the busy father of five.
5
5
Adam, 47, began experiencing vomiting and visual disturbances and initially thought he might have caught a bug.
But his symptoms didn't subside and continued for weeks.
Unable to stand up without being sick and increasingly concerned, he decided it was time to seek medical help.
'I was starting to worry it was cancer as cancer is a thing that has taken half of my family,' Adam, from Giffnock, East Renfrewshire, said.
'But no-one could give me an answer, no matter where I went. I went to the GP first and I was told 'it could be this, it could be that'.
'The only one I really remember is 'you might be heavily constipated '. When he said that, I couldn't believe it. I said to my wife Sharon 'we need to go somewhere else'.'
It took Adam 18 months to be diagnosed with multiple sclerosis (MS) and, surprisingly, he felt relieved.
'When the doctor said to me, 'It sounds to me like multiple sclerosis,' I said, 'Thank God!'' Adam recalled.
'And he said 'You do know what MS is?' And I said 'yeah, but it's not cancer.'
"We were at a different hospital and the minute we walked in there, it was as if somebody flicked a switch. From that moment on, life just got better. Regardless that I've got MS, at least I know what I'm dealing with.
Girl paralysed after giant critter feasted on her scalp
'I felt a big relief because I was thinking it was something that was going to kill me.'
Adam began to research the condition and decided to learn as much as he could.
In denial
MS is an often disabling disease that affects the central nervous system (brain and spinal cord).
He admits for the first two to three years he was in denial and believed that his life didn't need to change.
For the first few years he had Relapsing Remitting MS (RRMS) and he had several disease-modifying drugs to help slow down the progression of the illness.
'Some worked and some didn't,' he said.
'Many of the treatments have side effects that make you feel even worse on top of already being ill.
'Now I have Secondary Progressive MS (SPMS), which means I have moved onto the next stage, unfortunately. But I take medication and hopefully this will slow down the progression.'
Adam had to give up his job as a graphic designer and accept a slower pace of life.
"If I have to go to the kitchen, it might take me five minutes – but I'm OK with that,' he said.
'The main thing is: I'm still alive, I'm still breathing, so all is good.
'My wife is now my full time carer and I'm extremely lucky that she helps me get out and about.
'I still drive on occasion, it's the only thing that makes me feel normal like everyone else but mostly Sharon does it now.'
Sharon helps Adam with all the practicalities of MS, such as preparing his scooter, wheelchair or rollator and sorting routes, finding out where is accessible or where might have dodgy pavements.
'She deals with all of that so I don't need to because I can't anymore,' Adam added.
'I wouldn't leave the house, the anxiety of all of that on top of being ill would be crippling.
'In short, she just lets me concentrate on the MS itself.'
'It's not a one-size-fits-all thing with MS'
More than 150,000 people in the UK live with MS and many of them are unable to leave their house without help.
According to research by The MS Trust, 94 per cent of patients said their condition has affected their mental health with 60 per cent experiencing low self esteem.
Half of MS patients report feelings of isolation and loneliness.
Adam wants people to be aware that MS can present very differently in each person.
'There's not a set pattern to it,' he said.
'There could be a guy with MS who runs marathons and there could be someone in a wheelchair. It's not a one-size-fits-all thing.'
5
5
5
He is positive about his life and happy he's been able to be an active and present dad for his five children. 'When MS announced itself into my life, the youngest was five,' he said.
'I'm glad that my kids were of an age that my declining health wasn't going to impact them so much. They weren't going to grow up seeing dad be heavily disabled.
'I got to be a proper parent. I really didn't want MS to rob me of being a parent or to rob my kids of having a dad who was there.
'By the grace of God, it worked out and they're all doing their own things now. The youngest will be 20 this year. The oldest is in another country.
'I honestly haven't been happier and mentally clearer in my life. I just had this mental clarity one day: everything's going to be OK.
'It was like a massive weight came off me. I really can't explain it. It kind of is a spiritual experience - I think having MS has been like a superpower – for my mind, the way I think.
'Everyone's got problems. But when a problem comes up for me, I think, 'Is anybody going to die? No? Then there's no problem. We can fix it.''
What is multiple sclerosis (MS)?
Multiple sclerosis (MS) is a complex condition that affects the central nervous system, which includes the brain and spinal cord.
It's an autoimmune disease, meaning the body's immune system mistakenly attacks the protective coating (myelin) around nerve fibres.
This disrupts the flow of electrical signals and causes a range of symptoms that can vary wildly from person to person.
The good news? MS isn't a death sentence, and with advances in treatment, many people live full and active lives.
In the UK, over 130,000 people are living with MS, and around 7,000 new cases are diagnosed each year.
It's typically diagnosed in people in their 20s and 30s, with women three times more likely to develop it than men.
Despite its challenges, many with MS find strength and resilience they never thought possible.
Common symptoms of MS are:
Fatigue: Not your average tiredness—this is bone-deep exhaustion.
Vision problems: Blurred or double vision, or even temporary vision loss.
Numbness and tingling: Often in the face, arms, or legs.
Muscle weakness: Making everyday tasks feel like climbing a mountain.
Mobility issues: Trouble walking or balancing.
Cognitive difficulties: Memory lapses or a 'foggy' brain.
Spasms and stiffness: Muscles that just won't cooperate.
Bladder and bowel problems: A less glamorous but common challenge.
MS is unpredictable—you might have periods of remission where symptoms vanish, followed by flare-ups when they return.
This 'on-again, off-again' nature can be frustrating and means people can be in anticipation of a flare.
While there's no cure yet, treatments like disease-modifying therapies (DMTs), physiotherapy, and lifestyle changes can help manage symptoms and slow progression.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
an hour ago
- The Guardian
Houseplant clinic: what are those strange growths on my philodendron?
What's the problem? My philodendron has long, white, string-like growths coming out of the stems. Is my plant OK and can I cut them off? Diagnosis These curious structures are known as aerial roots, and are completely natural. Philodendrons originate from tropical rainforests, where they climb trees. These aerial roots help it anchor itself, absorb moisture and draw nutrients directly from the humid air. Indoors, however, they can give the plant a slightly wild appearance. Prescription There's no need for any concern or immediate action. Aerial roots are a sign of a healthy plant. If you find them visually unappealing, gently guide the roots on to a support, such as a moss pole or bamboo stake, to encourage your plant to climb. This helps it develop larger leaves and gives it an attractive shape. If you prefer to trim, use clean, sharp scissors to avoid damage or introducing infections. Prevention There's no need to prevent aerial root growth, but providing your plant with adequate support will keep it looking neat and encourage lush foliage. Got a plant dilemma? Email saturday@ with 'Houseplant clinic' in the subject line
The Guardian
5 hours ago
- The Guardian
The silent epidemic: the pros and cons of screening for prostate cancer
'You will feel a little pressure.' My doctor had instructed me to lower my boxers, bend forward and place my elbows on the table. As with most men over 50, it was time for my annual digital rectal exam, or DRE: those riveting moments when the doctor takes a 'look' at the prostate gland, which is just below the bladder and in front of the rectum. Its position makes the examination difficult. The physician inserts a well-lubricated finger into the patient's rectum to feel for abnormalities such as lumps, nodules or areas of hardness. As uncomfortable as the procedure can be, in my experience, it rarely lasts for more than 10 seconds. As always, she said everything looked fine. In my rush to pull my boxers up and change the subject, I didn't bother to ask any more questions. At the time, I was clueless that as men age, the prostate becomes increasingly susceptible to cancer. In the rare event the disease tops the news cycle, it's because of high-profile diagnoses, such as for former US president Joe Biden in May, Nelson Mandela, Robert De Niro and the Chicago Cubs hall of famer Ryne Sandberg, who died in late July. Even so, important details of the illness often go unreported. I – like many others – typically dismissed the topic with a yawn, being of the uninformed but persistent impression that it's 'the best cancer to have'. All I knew was that prostate cancer tends to move slowly and can be successfully treated when detected early. Now I am a prostate cancer survivor, whose prostatectomy in 2020 almost came too late. I didn't know that in the US, prostate cancer is the second leading cause of cancer death in men. One in eight will be diagnosed with it. One in 44 will die from it. Being uninformed about those details and testing options could have killed me. 'Prostate cancer has been called the Silent Epidemic,' said Dr Samuel L Washington, a urologic surgeon who specializes in oncology at the University of California in San Francisco. Even with an active lifestyle, healthy nutritional regimen and digital screenings, cancer can sneak in undetected. 'Many men with prostate cancer won't experience any outward signs or symptoms until the disease is advanced, which is why testing is so critical,' said Dr Clifford Gluck, a urologist and Founder of Dr Gluck's Wellness Center in Massachusetts. 'If not caught early, it can break free of the prostate and run unchecked through the body, with a particular penchant for bone.' Once prostate cancer has spread to other parts of the body, the five-year relative survival rate is only 37%. 'In 2023, only about 38% of men between 50 and 64 were screened for the disease,' said Washington. 'Sadly, a lack of screening remains one of many factors leading to increased rates of men presenting with more advanced disease over the last decade. The more advanced the cancer, the harder it is to treat.' Before my 62nd year, I routinely postponed my annual physical, assuming I was bulletproof. I was athletic and ate a plant-based diet. My life was free of processed foods, recreational drugs, tobacco, asbestos and weapons-grade plutonium. I experienced no symptoms indicative of prostate cancer, such as erectile dysfunction or urinary issues that reportedly led to the former president's diagnosis. Then, after a couple of cross-country moves with my family, I no longer had a primary physician. Dismissing my claims of invincibility, my wife handed me a list of internists. I booked a physical, and my new doctor ordered my first-ever PSA (prostate-specific antigen) test. PSA is a protein produced by the prostate. Normal and cancerous prostate cells produce it, but cancerous ones tend to produce more. That said, an elevated PSA level is not always indicative of cancer. Generally, a normal, or non-elevated score for men over 60 is under four; for men under 59, under two-and-a-half; and for younger men, under one. But 'PSA levels differ for each person,' said Dr Ash Tewari, professor and chairperson of the department of urology at the Icahn School of Medicine at Mount Sinai. 'While scores below four are preferred, it is most important to understand whether a PSA level is changing from year to year.' Variables such as family history, overall health, nutrition and race can have an effect. 'At the very least, I urge patients to have the conversation with their doctor,' he said. Mine was a harrowing 17. My doctor called, speaking with a breathless urgency that made me feel I might not live to the end of the conversation. 'It's almost certain,' he said, 'that you have prostate cancer.' The PSA test is a common, though imperfect, screening test for prostate cancer recommended by many urologists and primary care physicians for men starting at age 50. It is also one of the only ways to catch prostate cancer early. I asked my two previous primary care physicians why they had never ordered one, and they argued that the test sets off too many false alarms and causes undue stress; elevated PSA levels can be symptomatic of issues other than cancer, such as an infection. Also, I had never asked for one. (They must have confused my BA in English with a medical degree.) After hearing I had been diagnosed with prostate cancer, one conceded: 'In hindsight, a PSA test would have been a good idea.' Their reluctance is not unusual. Many doctors in the US shy away from prescribing the test because of the uncertainty of what an elevated score means, how patients react to that uncertainty and risks associated with subsequent exploratory procedures like biopsies. A PSA test can correctly indicate that prostate cancer is present, as it did for me. But it can also result in a false positive, suggesting cancer is present when it isn't (6 to 7% per screening round); a false negative, or not picking up that cancer is present (according to the UK's National Institute for Health and Care Excellence, 15% of people with a normal PSA test result may have prostate cancer); or catch slow-growing cancers that might never have caused issues. The latter is called overdiagnosis, and treatment can expose 'a person unnecessarily to potential complications', according to the National Cancer Institute: these include urine leakage, increased urination, loose stools or rectal bleeding, and loss of erections or decreased erections. Current estimates suggest that 20%–40% of screen-detected prostate cancers may never have caused harm, with risk varying by age, PSA levels, and Gleason Score. 'There are risks to the test,' said Dr Nancy L Keating, MD, MPH, professor of healthcare policy & medicine at Harvard Medical School. The PSA test has a C rating from the US Preventive Services Task Force (USPSTF). For context, an A rating means the USPSTF strongly recommends the test. A C means doctors may offer it, 'but that patients should make an individual decision about screening after discussing potential benefits and harms with their doctor', said Keating. Sign up to Well Actually Practical advice, expert insights and answers to your questions about how to live a good life after newsletter promotion 'There appears to be a modest benefit to screening for some men,' said Keating. 'But most prostate cancers are not likely to be deadly, and many men will experience the harms of screening, such as anxiety and unnecessary biopsies, and treatments like radiation or removal of the prostate that can lead to incontinence and erectile dysfunction, without experiencing benefits,' said Keating, who thinks it is important for patients to understand the test's limitations. In one 2024 study that followed more than 400,000 men aged 50-69, one invitation to do a PSA test produced a small mortality benefit. 'The small reduction in prostate cancer deaths by using the test to screen healthy men does not outweigh the potential harms,' Professor Richard Martin, lead author of the study and cancer research scientist at the University of Bristol in the UK, said at the time. 'This results in some men going on to have invasive treatment that they don't need, many years earlier than without screening, and the test is also failing to spot some cancers that do need to be treated.' Regret following a prostate biopsy isn't rare – even when no cancer is found. A 2024 multicenter cohort study reported that about 5% of men regretted undergoing the procedure, often due to pain, bleeding, or unexpected psychological distress. In qualitative studies, men who believed they had been overdiagnosed and unnecessarily treated reported lasting regret, uncertainty, and emotional distress – even years after treatment. Men more susceptible to prostate cancer, and therefore more likely to benefit from a PSA test, include African American men, men with a family history of prostate cancer, and those with genetic mutations such as BRCA1 or BRCA2, according to the American Cancer Society. Gluck noted that the PSA test has a low USPSTF grade 'primarily due to concerns about side-effects from surgery or radiation treatments'. But advances in technology, treatment and surgical techniques – such as high-intensity focused ultrasound (HIFU), a non-invasive treatment that uses targeted sound waves to destroy prostate cancer while preserving urinary and sexual function – make screening a 'far more favorable proposition' now, he said. My PSA score definitely spiked my anxiety, despite knowing I might only have an infection. The only way to determine what it meant was an MRI and a prostate biopsy. I dreaded the biopsy, which was to a digital exam what a root canal is to flossing. My urologist explained that there were some risks, such as infection and false negatives, but for me, confirming whether I had cancer far outweighed them. Nothing about these processes counted as pleasant. For the MRI, I was ensconced in the machine for about 40 minutes. A week after that, the doctor inserted an ultrasonic probe into my rectum to guide him as he extracted 12 small samples of my prostate. The biopsy redefined my concept of vulnerability, but although it seemed like hours, it took less than 20 minutes – and anticipating the pain was worse than the actual pain. After a few days of mild tenderness, I was back to normal. For all of the worry and discomfort, if the biopsy revealed no trace of cancer, I would have uncorked the champagne. Unfortunately, my results showed a high Gleason score – which measures how different cancer cells look under a microscope compared with normal cells – consistent with aggressive prostate cancer. But I was relieved to hear that the disease hadn't spread beyond the prostate membrane. Had I waited another two or three months, according to my post-operation pathology report, it probably would have. Six weeks after the biopsy, I underwent a radical robotic nerve-sparing prostatectomy, a roughly five-hour operation to remove the prostate using minimally invasive tools. Finding data on success rates was frustrating given the myriad factors that can affect the outcome, which include Gleason scores, age, health, obesity, comorbidities and whether or not the cancer has metastasized beyond the prostate. I banked on my fitness and the skill of my surgeon as deciding factors to undergo the operation. My greatest fears were long-term incontinence or erectile dysfunction, but I was fortunate not to suffer either. As lucky as I was, earlier testing and detection would have afforded me more treatment options. 'The benefits of early detection can't be overstated, which is why I advise men between 50 and 70 years of age to have a PSA discussion annually,' said Tewari. 'PSA screening combined with imaging is an important approach to effectively screen for prostate cancer.' It took moving across the country, my wife's diligence and a doctor who routinely prescribed PSA tests for my cancer to be diagnosed. It was a complicated road, and experts' divergence on the effectiveness of screening show just how difficult it can be for a layperson to make these kinds of medical decisions. It's not ideal to rely on a testing option that at best results in an estimated 10 out of 1,000 people avoiding death from prostate cancer, with treatment options that can result in incontinence and sexual dysfunction. But taking the test when I did had a dramatic impact. It saved my life. At the very least, I wish I'd had an earlier opportunity for a detailed discussion with my doctor. Given what I know now, I would have preferred screening and early detection, because for me, there is no such thing as the best type of cancer. Ed Manning is a 67-year-old technology executive, jazz pianist and freelance writer who is writing a memoir about surviving prostate cancer
Daily Mail
7 hours ago
- Daily Mail
NHS staff sickness rate highest for 10 years as levels rise in 18 Scottish health boards
Scotland's struggling NHS is facing even more pressure after it emerged sickness rates among staff have reached the highest level for ten years. A new report revealed the rate for 2024-25 was 6.4 per cent – up from 6.2 per cent the previous year. The NHS Education for Scotland report showed that was 'the highest rate in the past ten years'. It comes after the Scottish Tories claimed patients are 'dying needlessly' as A&E departments see waiting times worsening amid fears of a winter disaster. The latest worrying sickness rates come despite the fact that in 2009 the Scottish Government set a national target which aimed to reduce the NHS staff absence rate to 4 per cent. However, new figures for the year to the end of March showed that sickness absence rates decreased in four NHS boards and increased in 18. At the Scottish Ambulance Service, the sickness absence rate increased by 0.8 per cent to 9.7 per cent – the highest sickness absence rate of any health board. The data showed the health service employed 161,333.8 whole time equivalent (WTE) staff – up 0.1 per cent on the previous year. That included 67,714.6 WTE nursing and midwifery staff, with the number of absences amongst this group falling by 23.1 per cent to 2,601.2 WTE posts. As well as that, the figures detailed a reduction in spending on bank and agency staff. Spending on agency medical and dental staff dropped by 16.7 per cent to £108million. The bill for agency and bank nursing staff fell for the first time, to £410million, with this linked to falling spending on agency workers. The report said: 'After more than doubling in a three-year period, total nursing bank and agency expenditure decreased during the past year.' A Scottish Government spokesman said: 'Our aim is to limit all agency use as much as possible.' It comes as Public Health Scotland revealed more than a third of patients were not seen within the four-hour target last week in Scotland's A&E departments. Scottish Conservative health spokesman Dr Sandesh Gulhane said the figures were 'nothing short of disgraceful'. He said: 'How many more families need to lose loved ones before John Swinney and Neil Gray finally come up with a plan to address this crisis?' The proportion of patients admitted, transferred or discharged within four hours fell from 66.9 to 64.9 per cent last week, even though attendances were fractionally down. Mr Gray said: 'I know that some people are still waiting too long for treatment, and I am determined to drive improvement.' Other figures showed a 3.2 per cent increase in cancer deaths over the past decade, with lung cancer was the most common killer.
